Skip to main content
Signal8

ATWOOD BRIAN G

SEC insider (Form 3/4/5 filer). CIK 0001266567. Director at CERO THERAPEUTICS HOLDINGS, INC. (CERO). 13 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies ATWOOD BRIAN G has filed insider reports for

  • CERO THERAPEUTICS HOLDINGS, INC. (CERO): Director
ATWOOD BRIAN G profile photo

ATWOOD BRIAN G

CIK: 0001266567

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (15.4%)

Derivative conversions

Awards (A)9 (69.2%)

Compensation grants

Other (G, F, J, C, D, …)2 (15.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CERO THERAPEUTICS HOLDINGS, INC. logo
CERO

CERO THERAPEUTICS HOLDINGS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Jan 7, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    1.6M shares-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    May 30, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    122.5K shares-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Mar 31, 2025
    Exercise
    Indirect
    294.5K shares at avg. $0.00$29.446
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Mar 4, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    14.9K shares-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Feb 24, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    254K shares-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Feb 7, 2025
    Award

    Pre-Funded Warrant

    Indirect
    204.1K shares at avg. $0.00-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Feb 7, 2025
    Award

    Warrant to Purchase Shares of Common Stock

    Direct
    306.1K shares at avg. $1.96-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Feb 7, 2025
    Award

    Warrant to Purchase Shares of Common Stock

    Indirect
    204.1K shares at avg. $1.96-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Feb 7, 2025
    Award

    Pre-Funded Warrant

    Direct
    306.1K shares at avg. $0.00-
  • CERO THERAPEUTICS HOLDINGS, INC. logo
    CERO

    CERO THERAPEUTICS HOLDINGS, INC.

    Dec 2, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    254K shares-

1-10 of 13